LATEST MANUSCRIPTS IN Translational Medicine Communications
Shivani Thoidingjam, Sushmitha Sriramulu, Svend Freytag, Stephen L Brown, Jae Ho Kim, Indrin J Chetty, Farzan Siddiqui, Benjamin Movsas, Shyam Nyati. Oncolytic virus-based suicide gene therapy for cancer treatment: a perspective of the clinical trials conducted at Henry Ford Health.Translational medicine communications. 2023, 8 (1): 11
Victoria L M Herrera, Nicholas A Bosch, Judith J Lok, Mai Q Nguyen, Kaitriona A Lenae, Joanne T deKay, Sergey V Ryzhov, David B Seder, Nelson Ruiz-Opazo, Allan J Walkey. Circulating neutrophil extracellular trap (NET)-forming 'rogue' neutrophil subset, immunotype [DEspR + CD11b +], mediate multi-organ failure in COVID-19-.Translational medicine communications. 2023, 8 (1): 12
Débora C R F Porchera, Diana F V B Leal, Ana C O Braga, Pablo D C Pinto, Mayara N Santana da Silva, Lucas C Bezerra Santos, Cintia H Braga da Silva, Giovana E da Costa, Maria Clara da C Barros, Aidalucy do S C de Athayde, Amanda de N Cohen-Paes, Cleonardo A da Silva, Paulo P de Assumpção, Ândrea K C Ribeiro-Dos-Santos, Sidney E B Dos Santos, Marianne R Fernandes, Ney P C Dos Santos. Association of the rs4646994 in gene with susceptibility to tuberculosis in a region of the Brazilian Amazon.Translational medicine communications. 2022, 7 (1): 10
Valery Piacherski, Lidziya Muzyka, Dzyanis Zhylynski. COVID-19: positive experience with differentiated tactics of mechanical ventilation of the lungs for different phenotypes (L-phenotype).Translational medicine communications. 2022, 7 (1): 15
Marianno Franzini, Luigi Valdenassi, Sergio Pandolfi, Giovanni Ricevuti, Umberto Tirelli, Francesco Vaiano, Salvatore Chirumbolo. Comments on the optimal use of medical ozone in clinics versus the Ozone High Dose Therapy (OHT) approach.Translational medicine communications. 2022, 7 (1): 26
Gregory Thomas, Kristen Hirter, Elizabeth Frederick, Melissa Hausburg, Raphael Bar-Or, Yetti Mulugeta, Michael Roshon, Charles Mains, David Bar-Or. AMP5A modulates Toll-like receptors 7 and 8 single-stranded RNA immune responses in PMA-differentiated THP-1 and PBMC.Translational medicine communications. 2022, 7 (1): 3
Gerald Dieter Griffin. Does Covera-19 know 'when to hold 'em or 'when to fold 'em? A translational thought experiment.Translational medicine communications. 2021, 6 (1): 12
Kar Muthumani, Ziyang Xu, Moonsup Jeong, Joel N Maslow, Vaniambadi S Kalyanaraman, Alagarsamy Srinivasan. Preexisting vs. de novo antibodies against SARS-CoV-2 in individuals without or with virus infection: impact on antibody therapy, vaccine research and serological testing.Translational medicine communications. 2021, 6 (1): 13
Santosh Kesari, Gregory C Kasper, Lev Verkh, Terese C Hammond, Marla L Matal, Jay W Hammerling, Nikolai Tankovich, Adrianus P Lim, Kevin H Zhao, Tiffany Juarez, Roberta E Redfern, Jaya M Gill, Natsuko Nomura, Audrey Hiemer, Annie Heng, Jessica Shoemaker. Mesenchymal stem cells in the treatment of severe COVID-19.Translational medicine communications. 2021, 6 (1): 16
Ahsan Naveed, Deeba Naz, Sajjad Ur Rahman. Idiotype/anti-idiotype antibodies: as a glorious savior in COVID-19 pandemics.Translational medicine communications. 2021, 6 (1): 18
Santosh Kesari, Gregory C Kasper, Lev Verkh, Terese C Hammond, Marla L Matal, Jay W Hammerling, Nikolai Tankovich, Adrianus P Lim, Kevin H Zhao, Tiffany Juarez, Roberta E Redfern, Jaya M Gill, Natsuko Nomura, Audrey Hiemer, Annie Heng, Jessica Shoemaker. Correction to: Mesenchymal stem cells in the treatment of severe COVID-19.Translational medicine communications. 2021, 6 (1): 19